Header Logo

BRIAN MILES

TitleClinical Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Urology
Address6560 Fannin Ste#2100
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Riveros C, Ranganathan S, Haque W, Huang E, Xu J, Kulkarni GS, Geng M, Anis M, Muhammad T, Chan KS, Farach A, Teh BS, Miles BJ, Klaassen Z, Sonpavde GP, Wallis CJD, Satkunasivam R. Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation. Can Urol Assoc J. 2024 Feb; 18(2):17-24. PMID: 37931278; PMCID: PMC10841558.
      Citations:    
    2. Riveros C, Ranganathan S, Shah YB, Huang E, Xu J, Geng M, Melchiode Z, Hu S, Miles BJ, Esnaola N, Kaushik D, Jerath A, Wallis CJD, Satkunasivam R. Postoperative Discharge Destination Impacts 30-Day Outcomes: A National Surgical Quality Improvement Program Multi-Specialty Surgical Cohort Analysis. J Clin Med. 2023 Oct 26; 12(21). PMID: 37959249; PMCID: PMC10650337.
      Citations:    
    3. Riveros C, Ranganathan S, Huang E, Ordonez A, Xu J, Geng M, Miles BJ, Esnaola N, Klaassen Z, Jerath A, Kim SJ, Wallis CJD, Satkunasivam R. Glomerular hyperfiltration is an independent predictor of postoperative outcomes: A NSQIP multi-specialty surgical cohort analysis. Nephrology (Carlton). 2023 Oct; 28(10):548-556. PMID: 37468129.
      Citations:    Fields:    Translation:Humans
    4. G?mez G?mez E, Cano Casti?eira R, Burgos J, Rodr?guez Antol?n A, Miles BJ, Mart?nez Salamanca JI, Bianco F, Fern?ndez L, Calmarza I, Pastor J, Butler RG, de Pedro N. ProsTAV, a novel blood-based test for biopsy decision management in significant prostate cancer. Prostate. 2023 10; 83(14):1323-1331. PMID: 37409738.
      Citations:    Fields:    Translation:Humans
    5. Chu TN, Wong EY, Ma R, Yang CH, Dalieh IS, Hui A, Gomez O, Cen S, Ghazi A, Miles BJ, Lau C, Davis JW, Goldenberg MG, Hung AJ. A Multi-institution Study on the Association of Virtual Reality Skills with Continence Recovery after Robot-assisted Radical Prostatectomy. Eur Urol Focus. 2023 11; 9(6):1044-1051. PMID: 37277274; PMCID: PMC10693649.
      Citations:    Fields:    
    6. Riveros C, Ranganathan S, Nipper C, Lim K, Brooks M, Dursun F, Miles BJ, Goh AC, Desai M, Klaassen Z, Kulkarni GS, Wallis CJD, Satkunasivam R. Open vs. robot-assisted radical cystectomy with extracorporeal or intracorporeal urinary diversion for bladder cancer A pairwise meta-analysis of outcomes and a network meta-analysis of complications. Can Urol Assoc J. 2023 Mar; 17(3):E75-E85. PMID: 36473475; PMCID: PMC10027355.
      Citations:    
    7. Lim K, Riveros C, Ranganathan S, Xu J, Patel A, Slawin J, Ordonez A, Aghazadeh M, Morgan M, Miles BJ, Esnaola N, Klaassen Z, Allenson K, Brooks M, Wallis CJD, Satkunasivam R. Morbidity and mortality of multivisceral resection with radical nephrectomy for locally advanced renal cell carcinoma: An analysis of the National Surgical Quality Improvement Program (NSQIP) database. Urol Oncol. 2023 04; 41(4):209.e1-209.e9. PMID: 36801191.
      Citations:    Fields:    Translation:Humans
    8. Riveros C, Ranganathan S, Xu J, Chang C, Kaushik D, Morgan M, Miles BJ, Muhammad T, Anis M, Aghazadeh M, Zhang J, Efstathiou E, Klaassen Z, Brooks MA, Rini B, Wallis CJD, Satkunasivam R. Comparative real-world survival outcomes of metastatic papillary and clear cell renal cell carcinoma treated with immunotherapy, targeted therapy, and combination therapy. Urol Oncol. 2023 03; 41(3):150.e1-150.e9. PMID: 36610815.
      Citations: 2     Fields:    Translation:Humans
    9. Zhang A, Gupte AA, Chatterjee S, Li S, Ayala AG, Miles BJ, Hamilton DJ. Enhanced Succinate Oxidation with Mitochondrial Complex II Reactive Oxygen Species Generation in Human Prostate Cancer. Int J Mol Sci. 2022 Oct 12; 23(20). PMID: 36293021; PMCID: PMC9603078.
      Citations: 1     Fields:    Translation:HumansCells
    10. Celtik K, Wallis CJD, Lo M, Lim K, Lipscomb J, Fleming S, Wu XC, Anderson RT, Thompson TD, Farach A, Hamilton AS, Miles BJ, Satkunasivam R. Localized prostate cancer: An analysis of the Centers for Disease Control and Prevention Breast and Prostate Cancer Data Quality and Patterns of Care study (CDC PoC-BP). Can Urol Assoc J. 2022 Jul; 16(7):E391-E398. PMID: 35230935; PMCID: PMC9328859.
      Citations:    
    11. Satkunasivam R, Klaassen Z, Ravi B, Fok KH, Menser T, Kash B, Miles BJ, Bass B, Detsky AS, Wallis CJD. Relation between surgeon age and postoperative outcomes: a population-based cohort study. CMAJ. 2020 04 14; 192(15):E385-E392. PMID: 32392499; PMCID: PMC7162435.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    12. Satkunasivam R, Miles BJ. Editorial Comment. J Urol. 2020 02; 203(2):329. PMID: 31721683.
      Citations:    Fields:    Translation:Humans
    13. Haque W, Aghazadeh M, Miles BJ, Satkunasivam R, Butler EB, Teh BS. Clinical benefit of treatment for metastatic renal cell cancer at high volume facilities. Ann Transl Med. 2018 Dec; 6(Suppl 2):S90. PMID: 30740411; PMCID: PMC6330623.
      Citations:    
    14. Satkunasivam R, Tallman CT, Taylor JM, Miles BJ, Klaassen Z, Wallis CJD. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Meta-analysis of Oncologic, Perioperative, and Complication-related outcomes. Eur Urol Oncol. 2019 07; 2(4):443-447. PMID: 31277781.
      Citations: 14     Fields:    Translation:Humans
    15. Coarfa C, Florentin D, Putluri N, Ding Y, Au J, He D, Ragheb A, Frolov A, Michailidis G, Lee M, Kadmon D, Miles B, Smith C, Ittmann M, Rowley D, Sreekumar A, Creighton CJ, Ayala G. Influence of the neural microenvironment on prostate cancer. Prostate. 2018 Feb; 78(2):128-139. PMID: 29131367; PMCID: PMC5836952.
      Citations: 24     Fields:    Translation:Animals
    16. De Vivar AD, Sayeeduddin M, Rowley D, Cubilla A, Miles B, Kadmon D, Ayala G. Histologic features of stromogenic carcinoma of the prostate (carcinomas with reactive stroma grade 3). Hum Pathol. 2017 05; 63:202-211. PMID: 28315427.
      Citations: 7     Fields:    Translation:HumansCells
    17. Farach A, Ding Y, Lee M, Creighton C, Delk NA, Ittmann M, Miles B, Rowley D, Farach-Carson MC, Ayala GE. Neuronal Trans-Differentiation in Prostate Cancer Cells. Prostate. 2016 10; 76(14):1312-25. PMID: 27403603; PMCID: PMC5815867.
      Citations: 10     Fields:    Translation:HumansCells
    18. Aghazadeh MA, Mercado MA, Pan MM, Miles BJ, Goh AC. Performance of robotic simulated skills tasks is positively associated with clinical robotic surgical performance. BJU Int. 2016 Sep; 118(3):475-81. PMID: 27104883.
      Citations: 7     Fields:    Translation:Humans
    19. Chan R, Munoz A, Wenker EP, Whipple M, Miles B, Boone TB. Solifenacin and Tamsulosin Combination Therapy Decreases Urine Nerve Growth Factor/Creatinine Levels in Men. Urology. 2016 05; 91:150-3. PMID: 26829718.
      Citations:    Fields:    Translation:Humans
    20. Kim MJ, Divatia MK, Lee JH, Shen S, Miles BJ, Hwang JH, Ayala AG, Ro JY. Collagenous micronodules in prostate cancer revisited: are they solely associated with Gleason pattern 3 adenocarcinomas? Int J Clin Exp Pathol. 2015; 8(4):3469-76. PMID: 26097531; PMCID: PMC4466918.
      Citations: 2     Fields:    Translation:Humans
    21. Goh AC, Aghazadeh MA, Krasnow RE, Pastuszak AW, Stewart JN, Miles BJ. Robotic Intracorporeal Continent Cutaneous Urinary Diversion: Primary Description. J Endourol. 2015 Nov; 29(11):1217-20. PMID: 25556514; PMCID: PMC4702439.
      Citations: 9     Fields:    Translation:Humans
    22. Okoye E, Choi EK, Divatia M, Miles BJ, Ayala AG, Ro JY. De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature. Int J Clin Exp Pathol. 2014; 7(12):9061-6. PMID: 25674288; PMCID: PMC4313989.
      Citations: 10     Fields:    Translation:Humans
    23. Bianco FJ, Albala DM, Belkoff LH, Miles BJ, Peabody JO, He W, Bradt JS, Haas GP, Ahlering TE. A randomized, double-blind, solifenacin succinate versus placebo control, phase 4, multicenter study evaluating urinary continence after robotic assisted radical prostatectomy. J Urol. 2015 Apr; 193(4):1305-10. PMID: 25281778.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    24. Miyai K, Kristiansen A, Egevad L, Pina-Oviedo S, Divatia MK, Shen SS, Miles BJ, Ayala AG, Park YW, Ro JY. Seminal vesicle intraepithelial involvement by prostate cancer: putative mechanism and clinicopathological significance. Hum Pathol. 2014 Sep; 45(9):1805-12. PMID: 24993314.
      Citations:    Fields:    Translation:Humans
    25. Miyai K, Divatia MK, Shen SS, Miles BJ, Ayala AG, Ro JY. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions. Int J Clin Exp Pathol. 2014; 7(5):2518-26. PMID: 24966964; PMCID: PMC4069506.
      Citations: 15     Fields:    Translation:Humans
    26. Miyai K, Divatia MK, Shen SS, Miles BJ, Ayala AG, Ro JY. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion. Hum Pathol. 2014 Aug; 45(8):1572-81. PMID: 24842280.
      Citations: 10     Fields:    Translation:Humans
    27. Ding Y, He D, Florentin D, Frolov A, Hilsenbeck S, Ittmann M, Kadmon D, Miles B, Rowley D, Ayala G. Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer. Clin Cancer Res. 2013 Nov 15; 19(22):6101-11. PMID: 24097862; PMCID: PMC3898797.
      Citations: 22     Fields:    Translation:HumansCells
    28. Pastuszak AW, Pearlman AM, Lai WS, Godoy G, Sathyamoorthy K, Liu JS, Miles BJ, Lipshultz LI, Khera M. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013 Aug; 190(2):639-44. PMID: 23395803; PMCID: PMC4544840.
      Citations: 54     Fields:    Translation:Humans
    29. Stamatakis L, Cheng PJ, Ho PL, Thrall MJ, Mayer WA, Miles BJ, Link RE. A 60-year-old woman with an incidentally discovered right renal mass. Urology. 2012 Dec; 80(6):1183-6. PMID: 23206761.
      Citations: 1     Fields:    Translation:Humans
    30. Goh AC, Goldfarb DW, Sander JC, Miles BJ, Dunkin BJ. Global evaluative assessment of robotic skills: validation of a clinical assessment tool to measure robotic surgical skills. J Urol. 2012 Jan; 187(1):247-52. PMID: 22099993.
      Citations: 91     Fields:    Translation:Humans
    31. Sonpavde G, Thompson TC, Jain RK, Ayala GE, Kurosaka S, Edamura K, Tabata K, Ren C, Goltsov AA, Mims MP, Hayes TG, Ittmann MM, Wheeler TM, Gee A, Miles BJ, Kadmon D. GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy. Clin Cancer Res. 2011 Nov 15; 17(22):7174-82. PMID: 21933889; PMCID: PMC3865786.
      Citations: 19     Fields:    Translation:HumansCellsCTClinical Trials
    32. Cohen L, Parker PA, Vence L, Savary C, Kentor D, Pettaway C, Babaian R, Pisters L, Miles B, Wei Q, Wiltz L, Patel T, Radvanyi L. Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy. Psychosom Med. 2011 Apr; 73(3):218-25. PMID: 21257977.
      Citations: 17     Fields:    Translation:HumansCells
    33. Ayala GE, Muezzinoglu B, Hammerich KH, Frolov A, Liu H, Scardino PT, Li R, Sayeeduddin M, Ittmann MM, Kadmon D, Miles BJ, Wheeler TM, Rowley DR. Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens. Am J Pathol. 2011 Jan; 178(1):79-87. PMID: 21224046; PMCID: PMC3069909.
      Citations: 27     Fields:    Translation:Humans
    34. Moskovic DJ, Mohamed O, Sathyamoorthy K, Miles BJ, Link RE, Lipshultz LI, Khera M. The female factor: predicting compliance with a post-prostatectomy erectile preservation program. J Sex Med. 2010 Nov; 7(11):3659-65. PMID: 20819141.
      Citations: 11     Fields:    Translation:Humans
    35. Khavari R, Stamatakis L, Miles B. Robot-assisted laparoscopic prostatectomy performed in a patient with severe thrombocytopenia due to primary myelofibrosis. Can Urol Assoc J. 2009 Aug; 3(4):E23-E24. PMID: 19672431; PMCID: PMC2723872.
      Citations:    
    36. Mistry S, Mayer W, Khavari R, Ayala G, Miles B. Can Urol Assoc J. 2009 Jun; 3(3):205-210. PMID: 19543463; PMCID: PMC2692165.
      Citations: 4     
    37. Ayala GE, Dai H, Powell M, Li R, Ding Y, Wheeler TM, Shine D, Kadmon D, Thompson T, Miles BJ, Ittmann MM, Rowley D. Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res. 2008 Dec 01; 14(23):7593-603. PMID: 19047084.
      Citations: 122     Fields:    Translation:HumansAnimalsCells
    38. Ayala G, Yan J, Li R, Ding Y, Thompson TC, Mims MP, Hayes TG, MacDonnell V, Lynch RG, Frolov A, Miles BJ, Wheeler TM, Harper JW, Tsai MJ, Ittmann MM, Kadmon D. Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt. Clin Cancer Res. 2008 Nov 15; 14(22):7511-8. PMID: 19010869; PMCID: PMC2820291.
      Citations: 11     Fields:    Translation:HumansCellsCTClinical Trials
    39. Volk RJ, Jibaja-Weiss ML, Hawley ST, Kneuper S, Spann SJ, Miles BJ, Hyman DJ. Entertainment education for prostate cancer screening: a randomized trial among primary care patients with low health literacy. Patient Educ Couns. 2008 Dec; 73(3):482-9. PMID: 18760888; PMCID: PMC2867348.
      Citations: 51     Fields:    Translation:HumansPHPublic Health
    40. Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles BJ, Wheeler TM, Ayala GE. Reprint of: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy. Hum Pathol. 2008 Feb; 39(2):282-91. PMID: 18206496.
      Citations: 17     Fields:    
    41. Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles BJ, Wheeler TM, Ayala GE. Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy. Hum Pathol. 2007 Nov; 38(11):1611-20. PMID: 17868773.
      Citations: 40     Fields:    Translation:HumansCells
    42. Yang G, Addai J, Wheeler TM, Frolov A, Miles BJ, Kadmon D, Thompson TC. Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis. Hum Pathol. 2007 Nov; 38(11):1688-95. PMID: 17707459.
      Citations: 29     Fields:    Translation:HumansCells
    43. Teh BS, Bastasch MD, Mai WY, Kadmon D, Miles BJ, Butler EB. Preliminary report of the effect of high-dose adjuvant intensity modulated radiation therapy on the sural nerve graft for cavernosal nerve sacrifice after radical prostatectomy. Am J Clin Oncol. 2007 Aug; 30(4):395-400. PMID: 17762440.
      Citations:    Fields:    Translation:Humans
    44. Tahir SA, Frolov A, Hayes TG, Mims MP, Miles BJ, Lerner SP, Wheeler TM, Ayala G, Thompson TC, Kadmon D. Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. Clin Cancer Res. 2006 Aug 15; 12(16):4872-5. PMID: 16914574.
      Citations: 32     Fields:    Translation:Humans
    45. Miles BJ, Khera M. Can preoperative behavioral training reduce postprostatectomy incontinence? Nat Clin Pract Urol. 2006 Jun; 3(6):302-3. PMID: 16763638.
      Citations: 1     Fields:    Translation:Humans
    46. Sabichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, Minasian LM, Pisters LL, Caton JR, Basler JW, Lerner SP, Menter DG, Marshall JR, Crawford ED, Lippman SM. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2178-84. PMID: 16609032.
      Citations: 15     Fields:    Translation:Humans
    47. Ayala G, Satoh T, Li R, Shalev M, Gdor Y, Aguilar-Cordova E, Frolov A, Wheeler TM, Miles BJ, Rauen K, Teh BS, Butler EB, Thompson TC, Kadmon D. Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer. Mol Ther. 2006 Apr; 13(4):716-28. PMID: 16480930.
      Citations: 24     Fields:    Translation:HumansCellsCTClinical Trials
    48. Tetzlaff MT, Teh BS, Timme TL, Fujita T, Satoh T, Tabata K, Mai WY, Vlachaki MT, Amato RJ, Kadmon D, Miles BJ, Ayala G, Wheeler TM, Aguilar-Cordova E, Thompson TC, Butler EB. Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer. Technol Cancer Res Treat. 2006 Feb; 5(1):23-36. PMID: 16417399.
      Citations: 4     Fields:    Translation:HumansAnimals
    49. Subramanian VS, Coburn M, Miles BJ. Carcinosarcoma of the prostate with multiple metastases: case report and review of the literature. Urol Oncol. 2005 May-Jun; 23(3):181-3. PMID: 15907718.
      Citations: 5     Fields:    Translation:Humans
    50. Shariat SF, Naderi AS, Miles B, Slawin KM. Anomalies of the wolffian duct derivatives encountered at radical prostatectomy. Rev Urol. 2005; 7(2):75-80. PMID: 16985813; PMCID: PMC1477563.
      Citations: 12     
    51. Canto EI, Singh H, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection. J Urol. 2004 Sep; 172(3):900-4. PMID: 15310993.
      Citations: 8     Fields:    Translation:Humans
    52. Satoh T, Teh BS, Timme TL, Mai WY, Gdor Y, Kusaka N, Fujita T, Pramudji CK, Vlachaki MT, Ayala G, Wheeler T, Amato R, Miles BJ, Kadmon D, Butler EB, Thompson TC. Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients. Int J Radiat Oncol Biol Phys. 2004 Jun 01; 59(2):562-71. PMID: 15145177.
      Citations: 7     Fields:    Translation:HumansCellsCTClinical Trials
    53. Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Predictors of prostate cancer after initial negative systematic 12 core biopsy. J Urol. 2004 May; 171(5):1850-4. PMID: 15076292.
      Citations: 28     Fields:    Translation:Humans
    54. Canto EI, Singh H, Shariat SF, Lamb DJ, Mikolajczyk SD, Linton HJ, Rittenhouse HG, Kadmon D, Miles BJ, Slawin KM. Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer. Urology. 2004 May; 63(5):905-10; discussion 910-1. PMID: 15134977.
      Citations: 18     Fields:    Translation:Humans
    55. Teh BS, Ayala G, Aguilar L, Mai WY, Timme TL, Vlachaki MT, Miles B, Kadmon D, Wheeler T, Caillouet J, Davis M, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Aguilar-Cordova E, Butler EB. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1520-9. PMID: 15050332.
      Citations: 13     Fields:    Translation:HumansCellsCTClinical Trials
    56. Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. J Urol. 2004 Mar; 171(3):1089-92. PMID: 14767277.
      Citations: 29     Fields:    Translation:Humans
    57. Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy. J Urol. 2004 Jan; 171(1):204-9. PMID: 14665877.
      Citations: 6     Fields:    Translation:Humans
    58. Cunningham GR, Ashton CM, Annegers JF, Souchek J, Klima M, Miles B. Familial aggregation of prostate cancer in African-Americans and white Americans. Prostate. 2003 Sep 01; 56(4):256-62. PMID: 12858353.
      Citations: 14     Fields:    Translation:Humans
    59. Timme TL, Satoh T, Tahir SA, Wang H, Teh BS, Butler EB, Miles BJ, Amato RJ, Kadmon D, Thompson TC. Therapeutic targets for metastatic prostate cancer. Curr Drug Targets. 2003 Apr; 4(3):251-61. PMID: 12643475.
      Citations: 3     Fields:    Translation:HumansAnimals
    60. Simon MA, Miles BJ. Benign fibrous histiocytoma: a rare finding on bone scan staging for prostate adenocarcinoma. Urol Oncol. 2003 Jan-Feb; 21(1):45-7. PMID: 12684127.
      Citations:    Fields:    Translation:Humans
    61. Mouraviev V, Li L, Tahir SA, Yang G, Timme TM, Goltsov A, Ren C, Satoh T, Wheeler TM, Ittmann MM, Miles BJ, Amato RJ, Kadmon D, Thompson TC. The role of caveolin-1 in androgen insensitive prostate cancer. J Urol. 2002 Oct; 168(4 Pt 1):1589-96. PMID: 12352463.
      Citations: 17     Fields:    Translation:HumansAnimals
    62. Bastasch MD, Teh BS, Mai WY, Carpenter LS, Lu HH, Chiu JK, Woo SY, Grant WH, Miles BJ, Kadmon D, Butler EB. Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile function. Int J Radiat Oncol Biol Phys. 2002 Sep 01; 54(1):101-6. PMID: 12182979.
      Citations: 5     Fields:    Translation:Humans
    63. Gdor Y, Timme TL, Miles BJ, Kadmon D, Thompson TC. Gene therapy for prostate cancer. Expert Rev Anticancer Ther. 2002 Jun; 2(3):309-21. PMID: 12113054.
      Citations: 1     Fields:    Translation:HumansCells
    64. Shalev M, Mistry S, Kernen K, Miles BJ. Squamous cell carcinoma in a female urethral diverticulum. Urology. 2002 May; 59(5):773. PMID: 11992925.
      Citations: 10     Fields:    Translation:Humans
    65. Teh BS, Aguilar-Cordova E, Vlachaki MT, Aguilar L, Mai WY, Caillouet J, Davis M, Miles B, Kadmon D, Ayala G, Lu HH, Chiu JK, Carpenter LS, Woo SY, Grant WH, Wheeler T, Thompson TC, Butler EB. Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancer. Oncologist. 2002; 7(5):458-66. PMID: 12401909.
      Citations: 7     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    MILES's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (294)
    Explore
    _
    Co-Authors (37)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _